Home › Funds › FCPM III SERVICES B.V. › ENGN
FCPM III SERVICES B.V. position in ENGN
ENGENE THERAPEUTICS INC · Health Care
FCPM III SERVICES B.V. reported holding 9,632,561 shares of ENGN (ENGENE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$16.7M, representing 2.22% of its reported portfolio and ranking #9 among its reported holdings. FCPM III SERVICES B.V. has disclosed ENGN holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How FCPM III SERVICES B.V.'s ENGN position evolved
FCPM III SERVICES B.V. first disclosed a stake in ENGN in Q4 2023 at 8,677,951 shares (US$80.1M). The position peaked in Q1 2024 at 8,677,951 shares, worth US$147.1M. Across 11 filings, FCPM III SERVICES B.V. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 9,632,561 shares valued at US$16.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 8.68M | $80.10M | New |
| Q1 2024 | 8.68M | $147.09M | Hold |
| Q2 2024 | 8.68M | $81.83M | Hold |
| Q3 2024 | 8.68M | $57.27M | Hold |
| Q4 2024 | 9.63M | $64.06M | Add |
| Q1 2025 | 9.63M | $43.15M | Hold |
| Q2 2025 | 9.63M | $35.06M | Hold |
| Q3 2025 | 9.63M | $65.79M | Hold |
| Q4 2025 | 9.63M | $86.98M | Hold |
| Q1 2026 | 9.63M | $65.60M | Hold |
| Q2 2026 | 9.63M | $16.66M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ENGN and 13F data
ENGN (ENGENE THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in ENGN — the largest reported positions include BML Capital Management, LLC (US$11.5M), Nextech Invest Ltd. (US$4.0M), ACORN CAPITAL ADVISORS, LLC (US$2.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ENGN
- BML Capital Management, LLC 6.67M sh · $11.54M · Q2 2026
- Nextech Invest Ltd. 2.32M sh · $4.02M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.27M sh · $2.20M · Q2 2026
- Peapod Lane Capital LLC 1.04M sh · $2.08M · Q3 2026
- Omega Fund Management, LLC 876.36K sh · $1.52M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 747.75K sh · $1.29M · Q2 2026
- Kynam Capital Management, LP 457.86K sh · $792.09K · Q2 2026
- Elmind Capital, LP 210.00K sh · $363.30K · Q2 2026
More on FCPM III SERVICES B.V.
FAQ
How long has FCPM III SERVICES B.V. held ENGN?
FCPM III SERVICES B.V. has disclosed ENGN holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is FCPM III SERVICES B.V.'s current position in ENGN?
As of Q2 2026, FCPM III SERVICES B.V. holds 9.63M shares of ENGN (ENGENE THERAPEUTICS INC), valued at $16.66M, representing 2.22% of its reported portfolio and ranking #9.
Has FCPM III SERVICES B.V. been buying or selling ENGN?
In the latest 13F filing (Q2 2026), FCPM III SERVICES B.V. held unchanged its position in ENGN. The position peaked in Q1 2024 at 8.68M shares.
Which other funds hold ENGN?
Other major institutional holders of ENGN include BML Capital Management, LLC, Nextech Invest Ltd., ACORN CAPITAL ADVISORS, LLC, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.